Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
Original Article
P. Nathan, J.C. Hassel, P. Rutkowski, J.-F. Baurain, M.O. Butler, M. Schlaak, R.J. Sullivan, S. Ochsenreither, R. Dummer, J.M. Kirkwood, A.M. Joshua, J.J. Sacco, A.N. Shoushtari, M. Orloff, J.M. Piulats, M. Milhem, A.K. Salama, B. Curti, L. Demidov, L. Gastaud, C. Mauch, M. Yushak, R.D. Carvajal, O. Hamid, S.E. Abdullah, C. Holland, H. Goodall, and S. Piperno-Neumann
N Engl J Med 2021;385:1196-1206
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Saturday, September 23, 2023 - 11:59pm.